25841 Industrial Blvd
Fax: (650) 239-9070
RefleXion is a privately held therapeutic oncology company located in Hayward, Calif., transforming radiopharmaceuticals from diagnosing cancer to actively controlling delivery of external-beam radiotherapy by leveraging individual tumor biology. Designated an FDA Breakthrough Device, RefleXion’s SCINTIX™ biology-guided radiotherapy automates targeting and motion management to overcome long-standing barriers preventing definitive radiotherapy for metastatic disease. In strategic collaborations with radiopharmaceutical companies, RefleXion is co-developing and co-commercializing disease-specific radiopharmaceuticals for difficult to treat late-stage cancers. RefleXion’s vision is to extend the established safety, efficacy and cost-effectiveness of external-beam radiotherapy to patients with solid tumor malignancies of any stage.
The RefleXion® X1 with SCINTIX™ technology marries PET and CT, proven modalities for visualizing cancer, with radiotherapy, one of the most effective ways of treating cancer, in a dual-treatment modality platform.
31 articles about RefleXion
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the close of a $100 million equity financing led by Public Sector Pension Investment Board (PSP Investments), one of Canada’s largest pension investment managers that focuses on long-term investments with partners demonstrating strong value orientation strategies.
RefleXion Medical, a biotargeting oncology company using each cancer’s unique biology as a means to destroy it, today announced the opening of its new manufacturing facility at its headquarters in Hayward, Calif.
5/8/2019RefleXion will open a 50,000-square-foot manufacturing site later this month and add 50 employees by the end of the year.
The funds will support the completion of the FDA clearance process for their biology-guided BgRT system and its subsequent commercial launch.
Martyn Webster joins as CFO; Sean Shirvani, MD, joins as VP of Medical Affairs; Judy Bartlett-Roberto joins as VP of Marketing; Partha Ray joins as VP of Innovation Strategy; Len Lyons joins as VP of Sales
Reflexion Health Launches the Next-Generation of its Virtual Exercise Rehabilitation Assistant (VERA), Further Enhancing the Physical Therapy Experience For Patients and Clinicians
VERAHome and VERAClinic leverage avatar-led educational content, 3-D imaging with real-time feedback, and personalized care interventions to make recovery at home more engaging and more convenient than ever before
RefleXion Chooses MedCrypt To Provide Medical Device Security For First-To-Market Radiotherapy Technology